# Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers

> **NCT01325051** · PHASE1 · COMPLETED · sponsor: **Angela Kashuba, PharmD** · enrollment: 15 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01325051
- **Lead sponsor:** Angela Kashuba, PharmD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325051, "Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01325051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*